nicotine has been researched along with venlafaxine hydrochloride in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (83.33) | 29.6817 |
| 2010's | 1 (16.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cinciripini, L; Cinciripini, P; De Moor, C; Minna, J; Tomlinson, G; Tsoh, J; Wetter, D | 1 |
| Ciraulo, DA; Hennen, J; Jensen, JE; Ke, Y; Knapp, C; Kwak, T; Meyer, AA; Nassar, LE; Renshaw, PF; Sarid-Segal, O; Streeter, CC | 1 |
| Anderson, C; Baile, W; Cinciripini, L; Cinciripini, PM; de Moor, C; Lam, C; Minna, JD; Tsoh, JY; Wetter, DW | 1 |
| Czubak, A; Florek, E; Jodynis-Liebert, J; Kus, K; Nowakowska, E | 1 |
| Chen, TT; Cinciripini, PM; Lam, CY; Minna, JD; Minnix, JA; Robinson, JD; Tomlinson, GE; Wetter, DW | 1 |
| Burda, K; Czubak, A; Golembiowska, K; Kus, K; Metelska, J; Nowakowska, E | 1 |
4 trial(s) available for nicotine and venlafaxine hydrochloride
| Article | Year |
|---|---|
The effects of the DRD2 polymorphism on smoking cessation and negative affect: evidence for a pharmacogenetic effect on mood.
Topics: Adult; Affect; Antidepressive Agents, Second-Generation; Counseling; Cyclohexanols; Double-Blind Method; Female; Ganglionic Stimulants; Genotype; Humans; Male; Middle Aged; Nicotine; Placebos; Polymorphism, Genetic; Receptors, Dopamine D2; Smoking Cessation; Tobacco Use Disorder; Treatment Outcome; Venlafaxine Hydrochloride | 2004 |
Prefrontal GABA levels in cocaine-dependent subjects increase with pramipexole and venlafaxine treatment.
Topics: Adult; Antidepressive Agents, Second-Generation; Antioxidants; Benzothiazoles; Cocaine-Related Disorders; Cyclohexanols; Double-Blind Method; Female; gamma-Aminobutyric Acid; Humans; Magnetic Resonance Spectroscopy; Male; Middle Aged; Nicotine; Pramipexole; Prefrontal Cortex; Protons; Retrospective Studies; Thiazoles; Time Factors; Venlafaxine Hydrochloride | 2005 |
Combined effects of venlafaxine, nicotine replacement, and brief counseling on smoking cessation.
Topics: Administration, Cutaneous; Antidepressive Agents, Second-Generation; Counseling; Cyclohexanols; Diarrhea; Dizziness; Dose-Response Relationship, Drug; Double-Blind Method; Female; Headache; Humans; Male; Middle Aged; Nausea; Nicotine; Nicotinic Agonists; Patient Selection; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Time Factors; Tobacco Use Disorder; Treatment Outcome; Venlafaxine Hydrochloride | 2005 |
The DRD2 TaqI-B polymorphism and its relationship to smoking abstinence and withdrawal symptoms.
Topics: Administration, Cutaneous; Adult; Antidepressive Agents, Second-Generation; Cyclohexanols; Double-Blind Method; Female; Gene Frequency; Genotype; Homozygote; Humans; Linkage Disequilibrium; Male; Middle Aged; Nicotine; Nicotinic Agonists; Phenotype; Polymorphism, Genetic; Receptors, Dopamine D2; Severity of Illness Index; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Time Factors; Venlafaxine Hydrochloride | 2007 |
2 other study(ies) available for nicotine and venlafaxine hydrochloride
| Article | Year |
|---|---|
The influence of tobacco smoke and nicotine on antidepressant and memory-improving effects of venlafaxine.
Topics: Animals; Antidepressive Agents, Second-Generation; Atmosphere Exposure Chambers; Behavior, Animal; Cyclohexanols; Depression; Female; Maze Learning; Memory; Motor Activity; Nicotine; Nicotinic Agonists; Rats; Rats, Wistar; Smoking; Swimming; Venlafaxine Hydrochloride | 2006 |
Effect of venlafaxine and nicotine on the level of neurotransmitters and their metabolites in rat brains.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Antidepressive Agents, Second-Generation; Cyclohexanols; Dopamine; Female; Ganglionic Stimulants; Hippocampus; Homovanillic Acid; Hydroxyindoleacetic Acid; Microdialysis; Neurotransmitter Agents; Nicotine; Norepinephrine; Rats; Rats, Wistar; Serotonin; Venlafaxine Hydrochloride | 2010 |